Muromonab
- Generic Name
- Muromonab
- Brand Names
- -
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- 140608-64-6
- Unique Ingredient Identifier
- JGA39ICE2V
- Background
Murine monoclonal antibody specific to CD3 T-cell lymphocyte antigens. More specifically it is a purified murine (mouse) monoclonal antibody, directed against the CD3 (T3) receptor on the surface of human T-cells (T-lymphocytes) cultured using the murine ascites method. Muromonab is 93% monomeric immune globulin G type 2a (IgG2a).
- Indication
For treatment of organ transplant recipients, prevention of organ rejection
- Associated Conditions
- Acute Renal Allograft Rejection, Steroid resistant Heart transplant rejection, Steroid resistant hepatic transplant rejection
- Associated Therapies
- -
No trials found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath